Status:
COMPLETED
Tobacco Use and the Risk of COVID-19 and Adverse Outcomes
Lead Sponsor:
Karolinska Institutet
Collaborating Sponsors:
Finnish Institute for Health and Welfare
Norwegian Institute of Public Health
Conditions:
COVID-19
Respiratory Tract Infections
Eligibility:
All Genders
20+ years
Brief Summary
This is an observational study of pooled population-based samples in three Nordic countries. Country-specific data has already been analysed in previous studies in Sweden, Finland, and Norway. The pri...
Detailed Description
The coronavirus disease (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has caused more than 470 million confirmed cases of COVID-19, and more than 6 milli...
Eligibility Criteria
Inclusion
- Exclusion Criteria:
- • All subjects who died before the onset of the pandemic (February 2020) in the three countries will be excluded from the analysis.
Exclusion
Key Trial Info
Start Date :
April 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2023
Estimated Enrollment :
757585 Patients enrolled
Trial Details
Trial ID
NCT05321433
Start Date
April 1 2022
End Date
December 31 2023
Last Update
March 6 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Karolinska Institutet
Solna, Stockholm County, Sweden, 171 77